DK1404291T3 - Vandfrit ubiquinon-koncentrat - Google Patents

Vandfrit ubiquinon-koncentrat

Info

Publication number
DK1404291T3
DK1404291T3 DK02743249T DK02743249T DK1404291T3 DK 1404291 T3 DK1404291 T3 DK 1404291T3 DK 02743249 T DK02743249 T DK 02743249T DK 02743249 T DK02743249 T DK 02743249T DK 1404291 T3 DK1404291 T3 DK 1404291T3
Authority
DK
Denmark
Prior art keywords
concentrate
anhydrous
ubiquinone
ubichinon
sub
Prior art date
Application number
DK02743249T
Other languages
Danish (da)
English (en)
Inventor
Dariush Behnam
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7691172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1404291(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aquanova Ag filed Critical Aquanova Ag
Application granted granted Critical
Publication of DK1404291T3 publication Critical patent/DK1404291T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Confectionery (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK02743249T 2001-07-12 2002-06-29 Vandfrit ubiquinon-koncentrat DK1404291T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10133305A DE10133305B4 (de) 2001-07-12 2001-07-12 Ubichinon Konzentrat
PCT/EP2002/007195 WO2003007907A1 (fr) 2001-07-12 2002-06-29 Concentre d'ubichinon anhydre

Publications (1)

Publication Number Publication Date
DK1404291T3 true DK1404291T3 (da) 2009-02-02

Family

ID=7691172

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02743249T DK1404291T3 (da) 2001-07-12 2002-06-29 Vandfrit ubiquinon-koncentrat

Country Status (12)

Country Link
US (1) US7094804B2 (fr)
EP (1) EP1404291B1 (fr)
JP (1) JP2004534853A (fr)
CN (1) CN1545406A (fr)
AT (1) ATE409022T1 (fr)
CA (1) CA2453473A1 (fr)
DE (3) DE10133305B4 (fr)
DK (1) DK1404291T3 (fr)
ES (1) ES2315370T3 (fr)
MX (1) MXPA04000349A (fr)
RU (1) RU2287981C2 (fr)
WO (1) WO2003007907A1 (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10133305B4 (de) 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat
EP1505952A1 (fr) 2002-05-22 2005-02-16 Unilever N.V. Procede de preparation d'une composition cosmetique et composition cosmetique preparee selon ce procede
DE10243437A1 (de) * 2002-09-18 2004-04-29 Pm-International Ag Kosmetische Formulierung
EP1602286B1 (fr) * 2003-03-11 2009-10-28 Kaneka Corporation Emulsion de type huile-dans-eau renfermant un coenzyme q10 et procede d'obtention
EP1603515A1 (fr) * 2003-03-12 2005-12-14 Unilever N.V. Procede de preparation d'une composition pour soins d'hygiene personnelle a partir d'un concentre
US20070043106A1 (en) * 2005-08-18 2007-02-22 Dariush Behnam Alpha-lipoic acid concentrate
US20060287384A1 (en) * 2004-08-18 2006-12-21 Dariush Behnam Lipoic acid concentrate
JP5147239B2 (ja) * 2004-09-29 2013-02-20 三栄源エフ・エフ・アイ株式会社 コエンザイムｑ１０含有乳化組成物
US8961958B2 (en) * 2004-11-16 2015-02-24 Bioavailability, Inc High concentration self-microemulsifying coenzyme Q10 preparations for nutritional use
DE102006010809B4 (de) * 2006-03-07 2009-10-22 Aquanova Ag Solubilisat eines Konservierungsmittels
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
MY153288A (en) * 2006-06-28 2015-01-29 Hovid Berhad An effective pharmaceutical carrier for poorly bioavailable drugs
JP5028885B2 (ja) * 2006-07-04 2012-09-19 大正製薬株式会社 ユビデカレノン含有自己乳化組成物
CN101516357A (zh) 2006-09-22 2009-08-26 米维塔尔股份公司 包含阿拉伯胶的乳剂
US20080145411A1 (en) * 2006-10-06 2008-06-19 Kaneka Corporation Composition of high absorbability for oral administration comprising oxidized coenzyme q10
US20100196456A1 (en) * 2007-05-09 2010-08-05 Daniel Strasser Emulsion preconcentrates and micellar formulations containing wood resins
US20090130198A1 (en) 2007-11-21 2009-05-21 Innopharmax Inc. Pharmaceutical composition with enhanced bioavailability
EP2548456B1 (fr) 2008-03-20 2015-07-08 Virun, Inc. Émulsions comprenant un dérivé de peg de tocophérol
MX2010010214A (es) 2008-03-20 2010-12-21 Virun Inc Derivados de vitamina e y sus usos.
US8337931B2 (en) * 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
CH699449A2 (de) * 2008-08-27 2010-03-15 Mivital Ag Emulsionsvorkonzentrate sowie micellare Formulierungen enthaltend Glycerinfettsäureester.
US8445037B2 (en) * 2008-10-28 2013-05-21 A. M. Todd Company Volatile distillate by-product of mint oil that promotes absorption and/or bioavailability of compounds of bio-medical and nutritional interest
RU2405542C2 (ru) * 2008-11-19 2010-12-10 Закрытое акционерное общество "Санкт-Петербургский институт фармации" Мягкая экструзионная капсула, способ приготовления раствора для ее наполнения, способ получения капсул и способ увеличения плотности агаровой оболочки
US9005608B2 (en) * 2009-03-24 2015-04-14 Adds Pharmaceuticals Llc Stabilized solubility-enhanced formulations for oral delivery
DE102009025215B4 (de) 2009-06-17 2025-03-27 Carl Zeiss Vision International Gmbh Methode und Vorrichtung zur Zentrierdatenermittlung
KR101907411B1 (ko) 2010-03-12 2018-10-12 베르그 엘엘씨 코엔자임 Ｑ10(ＣｏＱ10)의 정맥내 제형 및 이의 사용 방법
CA2792330C (fr) * 2010-03-23 2017-01-03 Virun, Inc Nanoemulsion comportant un derive peg de vitamine e et un sucrose ester d'acide gras
US8741373B2 (en) 2010-06-21 2014-06-03 Virun, Inc. Compositions containing non-polar compounds
CN107095863A (zh) 2011-06-17 2017-08-29 博格有限责任公司 可吸入药物组合物
CA2863544C (fr) 2012-02-10 2019-03-26 Virun, Inc. Compositions de boisson contenant des composes non polaires
AU2013264767A1 (en) 2012-05-22 2014-11-27 Laila Pharmaceuticals Pvt. Ltd. Novel highly bioavailable, water soluble and sustained release nanoformulations of hydrophobic plant derived compounds and extracts
JP5999765B2 (ja) * 2012-12-07 2016-09-28 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
JP5722299B2 (ja) * 2012-12-07 2015-05-20 バイオアバイラビリティ，インク． 栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムｑ１０調製物
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
WO2017045034A1 (fr) * 2015-09-17 2017-03-23 Pharmako Biotechnologies Pty Limited Compositions d'ubiquinone et d'ubiquinol, et procédés associés
EP3290026A1 (fr) 2016-09-06 2018-03-07 Athenion AG Procédé de solubilisation de compléments diététiques faiblement solubles dans l'eau et agents pharmaceutiquement actifs
EP3511325A1 (fr) * 2018-01-11 2019-07-17 MetrioPharm AG Procédé pour solubiliser 5-amino-2,3-dihydro-1,4-phthalazinedione
EP3536332A1 (fr) 2018-03-07 2019-09-11 Athenion AG Huile de krill pour la solubilisation de compléments alimentaires faiblement solubles dans l'eau et agents pharmaceutiquement actifs
EP3919046A1 (fr) 2020-06-02 2021-12-08 Athenion AG Procédé de solubilisation de cannabinoïdes naturels, endogènes et synthétiques
EP4186497A1 (fr) 2021-11-26 2023-05-31 Dorian Bevec Acide alpha lipoïque, epigallocatéchin-3-gallate,curcumine comme médicament pour le traitement de l'arthrose pour le l'traitment ou d'une infection sars-cov-2
WO2023199908A1 (fr) * 2022-04-11 2023-10-19 株式会社ダイセル Procédé de production d'une composition émulsifiée

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581813A (en) 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JPS5618914A (en) 1979-07-25 1981-02-23 Eisai Co Ltd Ubidecarenone composition having good absorbability
DE3224619A1 (de) 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
JPS60199814A (ja) 1984-03-24 1985-10-09 Taisho Pharmaceut Co Ltd ユビデカレノン脂肪乳剤
EP0179583A1 (fr) * 1984-10-04 1986-04-30 Merck & Co. Inc. Système pour augmenter la vitesse de dissolution dans l'eau et la solubilité de médicaments peu solubles
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
JPS62123113A (ja) 1985-11-22 1987-06-04 Green Cross Corp:The ユビデカレノン含有脂肪乳剤
IT1263840B (it) * 1993-03-30 1996-09-04 Giuseppe Furiosi Formulazioni orali di ubidecarenone in forma di capsule
WO1995025084A1 (fr) * 1994-03-14 1995-09-21 Morten Sloth Weidner Procede permettant de rendre des composes organiques solubles dans les systemes gras, nouveaux complexes chimiques de tels composes et leurs diverses applications
US6056971A (en) 1996-07-24 2000-05-02 Biosytes Usa, Inc. Method for enhancing dissolution properties of relatively insoluble dietary supplements and product incorporating same
DE19647352C2 (de) * 1996-11-15 2000-06-29 Aqua Nova Getraenketechnologie Nicht alkoholisches Getränk mit einem Gehalt an Q 10
US6200550B1 (en) * 1998-12-11 2001-03-13 Q-Pharma, Inc. Oral care compositions comprising coenzyme Q10
US8753675B1 (en) * 2000-01-20 2014-06-17 Raj K. Chopra Reduced form of Coenzyme Q in high bioavailability stable dosage forms and related applications
DE10104847B4 (de) * 2000-06-09 2006-12-21 Aquanova German Solubilisate Technologies (Agt) Gmbh Tocopherol-Konzentrat und Verfahren zu seiner Herstellung
US6300377B1 (en) 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
ATE253353T1 (de) 2001-04-12 2003-11-15 Vesifact Ag Coenzym q10 enthaltende mikroemulsion- prekonzentrate und mikroemulsionen
DE10133305B4 (de) 2001-07-12 2004-06-03 Aquanova German Solubilisate Technologies (Agt) Gmbh Ubichinon Konzentrat

Also Published As

Publication number Publication date
CN1545406A (zh) 2004-11-10
JP2004534853A (ja) 2004-11-18
CA2453473A1 (fr) 2003-01-30
HK1067297A1 (zh) 2005-04-08
DE10133305A1 (de) 2003-02-13
RU2004103975A (ru) 2005-03-27
DE50212809D1 (de) 2008-11-06
DE20122900U1 (de) 2009-12-03
RU2287981C2 (ru) 2006-11-27
EP1404291B1 (fr) 2008-09-24
WO2003007907A1 (fr) 2003-01-30
EP1404291A1 (fr) 2004-04-07
DE10133305B4 (de) 2004-06-03
US20030165438A1 (en) 2003-09-04
ATE409022T1 (de) 2008-10-15
ES2315370T3 (es) 2009-04-01
US7094804B2 (en) 2006-08-22
MXPA04000349A (es) 2005-03-07

Similar Documents

Publication Publication Date Title
ATE409022T1 (de) Wasserfreies ubichinon-konzentrat
AR066694A2 (es) Metodo para la preparacion de citalopram
ATE181551T1 (de) Taxol-derivate
DK258590A (da) Forbedrede emulsioner af staerkt fluorerede organiske forbindelser
ES2195970T3 (es) L-ribavirina y usos de la misma.
AU2001278587A1 (en) Method for delivering chemicals to an oil or gas well
GB0120033D0 (en) Cell selection
BR0006005A (pt) Composição estável de óleo em glicerinatopicamente aplicável
KR970027031A (ko) 일차 또는 이차 알콜의 산화방법
NO913379D0 (no) Oljebaserte boreslam.
TR199700418A3 (tr) Fluorlu D3 vitamini analoglari.
DE50210038D1 (de) Implantat mit oberflächenstruktur
AU1413901A (en) Id symbol unique to structural formula of compound
BR0302111A (pt) Método para marcar um hidrocarboneto de petróleo lìquido
DE69941786D1 (de) Chemolumineszente 1,2-dioxetane
ATE457650T1 (de) Stabile öl in wasser emulsion
AU9069201A (en) Interheteroaryl 7-oxabicyclic (2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
AU9259501A (en) Interphenylene 7-oxabicyclic(2.2.1)heptane oxazoles as prostaglandin F<sub>2alpha</sub> antagonists
DE59200637D1 (de) Bohrer zur Herstellung von Bohrlöchern mit Hinterschneidung.
ATE277060T1 (de) 1,5-anhydro-d-fruktose substituiert mit einer hydrophoben gruppe zur verwendung als antioxidant und/oder emulgator
TW200506526A (en) Bridged carbocyclic compounds and methods of making and using same
WO2002098924A3 (fr) Compositions contenant des peroxydes fluores, leurs procedes d'elaboration et leur utilisation
DE50112118D1 (de) Verwendung von Alkyl(ether)phosphaten(I)
EA200001076A1 (ru) Способ получения 4-замещенных-1h-индол-3-глиоксамидов
BR0113130A (pt) Processo para a preparação de um composto, compostos, e, processo para a preparação de fitona e/ou vitamina e